期刊文献+

本周氏蛋白催化作用与多发性骨髓瘤患者肾损伤的关系 被引量:5

Relationship between the Catalysis of Bence Jones Protein and Renal Impairment in Patients with Multiple Myeloma
下载PDF
导出
摘要 本研究通过体外细胞实验观察多发性骨髓瘤(MM)患者尿中本周氏蛋白(Bence Jones protein,BJP)酰胺酶催化作用与肾小管细胞毒性作用的关系,进一步了解BJP对MM肾损伤的毒性机制。测定13例MM患者尿BJP的酰胺酶动力学参数米氏常数(Km)和催化常数(kcat);以不同浓度BJP与猪肾小管上皮细胞(LLC-PK1)共同培养24 h后,用MTT法测定细胞增殖抑制率;以明显抑制细胞增殖的BJP浓度与LLC-PK1细胞共同培养后使用流式细胞术检测细胞凋亡。结果表明,临床出现肾损伤的MM患者尿中BJP较未出现肾损伤MM患者尿中BJP更易对LLC-PK1细胞产生毒性作用,且BJP的kcat值越高,对LLC-PK1细胞毒性作用越强。流式细胞仪检测发现,BJP能够诱导LLC-PK1细胞发生凋亡及坏死,毒性作用随BJP浓度的增高而增强。结论:BJP能够对肾小管上皮细胞产生直接毒性作用,并随BJP浓度的增高而增强;BJP酰胺酶催化作用强度与其毒性作用呈正相关,其可能是MM患者发生肾损伤的机制之一。 This study was purposed to investigate the relationship between the catalysis of Bence Jones protein(BJP) in urine of patients with multiple myeloma(MM) and toxicity on the renal proximal tubular cells in vitro,and to explore the potential mechanism for the toxicity of BJP to renal impairment in patients with MM.The Michaelis-Menten constant(Km) and catalytic constant(kcat) of the amidase activity of BJP was calculated by Hanes equation.The LLC-PK1 cells were cultured with different concentration of BJP for 24 h,then proliferation of the cells were determined by MTT method and apoptosis were determined by flow cytometry.The results showed that the BJP from the MM patients with renal impairment significantly inhibited cell proliferation,as compared with that from MM patients without renal impairment.The BJP with higher kcat had higher toxicity to LLC-PK1 cells.BJP could induce apoptosis and necrosis of LLC-PK1 cells when reached a certain concentration and this effect enhanced with increase of BJP concentration.It is concluded that the catalysis of BJP and its toxicity to renal tubular epithelial cells has a positive correlation,and toxic effect of BJP on renal tubular epithelial cells results from inhibiting proliferation and inducing apoptosis and necrosis of the cells,which may be one of renal impairment mechenisms in MM patients.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第2期339-343,共5页 Journal of Experimental Hematology
基金 南京军区医学科技创新经费资助项目(编号10MA096)
关键词 本周氏蛋白 多发性骨髓瘤 LLC-PK1细胞 肾损伤 催化作用 Bence Jones protein multiple myeloma LLC-PK1 cell renal impairment catalysis
  • 相关文献

参考文献12

  • 1Roussou M, Kastritis E, Migkou M, et al. Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens. Leuk Lymphoma, 2008 ; (49) : 890 - 895.
  • 2邹剑峰(综述),侯健(审校).多发性骨髓瘤的肾损害的发病机制及防治进展[J].国际输血及血液学杂志,2007,30(4):323-327. 被引量:14
  • 3Matsuura K, Yamamoto Y, Sinohara H. Amidase activity of human Bence Jones proteins. Biochem Biophys Res Commun, 1994; 204 (1) :57 -62.
  • 4Matsuura K, Ikoma S, Watanahe M, et al. Some Bence-Jones pro-teins enter cultured renal tubular ceils, reach nuclei and induce cell death. Immunology, 1999; 98(4) : 584 -589.
  • 5Huang ZQ, Sanders PN. Localization of single binding site for immu- noglobulin light chains on human Tamm-Horsfall glycoprotein. J Clin Invest, 1997; 99(4): 732-760.
  • 6周振海,李小银,李娟,罗绍凯,李幼姬,洪文德.尿本周蛋白促进肾小管上皮细胞凋亡的体外研究[J].现代免疫学,2005,25(4):274-278. 被引量:6
  • 7Sanders PW, Herrera GA, Galla JH. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int, 1987; 32 (6): 851 -861.
  • 8Sanders PW, Herrera GA, Lott RL, et al. Morphologic alterations of the proximal tubules in light chain-related renal disease. Kidney Int, 1988; 33(4): 881 -889.
  • 9Guan S, el-Dahr S, Dipp S, et al. Inhibition of Na-K-ATPase activi- ty and gene expression by myeloma light chain in proximal tubule celles. J lnvestig Med, 1999; 47(9) : 496 -501.
  • 10Matuura K, Ikoma S, Yoshida K, et al. DNA-hydrolyzing activity of Bence Jones proteins. Biochem Biophys Res Commun, 1998; 243 (3) :719 -721.

二级参考文献33

  • 1袁颖,熊小敏,郑立.多发性骨髓瘤119例临床分析[J].华西医学,2006,21(1):120-121. 被引量:6
  • 2章友康.多发性骨髓瘤肾损害[J].中国中西医结合肾病杂志,2006,7(3):125-128. 被引量:18
  • 3Huang ZQ, Sanders PN. Localization of single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein [J]. J Clin Invest, 1997,99(4):732-760.
  • 4Solmon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones protein[J]. New Engl J Med, 1991,324(26):1845-1851.
  • 5Clark AD, Shetty A, Soutar R. Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma[J]. Blood Rev, 1999,13(2):79-90.
  • 6Rostagno A, Vidal R, Kaplan B, et al. pH-dependent fibrinogenesis of a VκⅢ Bence Jones protein[J]. Br J Haematol, 1999,107(4):835-843.
  • 7Matsuura K, Ikomas S, Watanabe MI, et al. Some Bence Jones proteins enter cultured renal tubular cells, reach nuclei and induce cell death[J]. Immunology, 1999,98(4):584-589.
  • 8霍夫曼.血液病学:基本原理与实践[M].第3版(英文影印版)[M].北京:科学出版社,2001.1401-1492.
  • 9Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic myeloma study group[J]. Eur J Haematol, 2000,65(3):175-181.
  • 10Pote A, Zwizinsi C, Simon E, et al. Cytotoxicity of myeloma light chains in cultured human kidney proximal tubule cells[J].Am J Kidney Dis, 2000,36(4):125-131.

共引文献17

同被引文献21

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部